The global Glucose Tolerance Test Market is predicted to touch USD 46,815.0 million at a 10.4% CAGR between 2014- 2023, as per the recent analysis by Market Research Future (MRFR). A glucose tolerance test, simply put, is a test that helps to measure how well the cells in a body can engross sugar or glucose after the patient consumes a certain amount of sugar.
Various factors are propelling the global glucose tolerance test market growth. As per the latest MRFR report, such factors include changing lifestyle, urbanization, rising prevalence of diabetes across the world, increasing healthcare awareness, rising lifestyle associated diseases, increasing obese population, and growing aging population.
On the contrary, limited reimbursement, high diagnosis and treatment cost, and the availability of affordable alternative technologies are factors that may limit the global glucose tolerance test market growth over the forecast period. Besides, the grave impact of the ongoing COVID-19 outbreak is also impacting the market growth.
Request For Free Sample Copy :https://www.marketresearchfuture.com/sample_request/4921
The MRFR report offers an inclusive segmental analysis of the global glucose tolerance test market report based on product, indication, and end user.
By product, the global glucose tolerance market is segmented into smart sensors, blood glucose testing kit, and others. The blood glucose testing kit is further segmented into test strips, meters, lancet, and others. Of these, the blood glucose testing kit segment will lead the market over the forecast period. Burgeoning demand for home care for diabetes, rising cases of diabetes, and easy accessibility and use are adding to the segment growth. It is predicted to touch USD 36,164.0 million by 2023.
By indication, the global glucose tolerance test market is segmented into reactive hypoglycaemia, insulin resistance, gestational diabetes, and diabetes. Of these, the diabetes segment will dominate the market over the forecast period. The rising cases of diabetes are adding to the growth of the segment.
By end users, the global glucose tolerance test market is segmented into home, hospitals, and diagnostic clinics. Of these, the diagnostics clinics will have a major share in the market over the forecast period.
Based on the region, the global glucose tolerance test market report covers the growth opportunities and recent trends across the Americas, Europe, the Asia Pacific, & the Middle East and Africa. Of these, the Americas will lead the market over the forecast period. High healthcare expenditure, well-developed technology, and the rising cases of diabetes mellitus (DM) are adding to the global glucose tolerance test market growth in the region.
The global glucose tolerance test market in Europe is predicted to hold the second-largest share over the forecast period. The presence of a growing geriatric population, well-developed healthcare infrastructure, and increasing support from the government for R&D are adding to the global glucose tolerance test market growth in the region.
The global glucose tolerance test market in the APAC region is predicted to grow at a fast pace over the forecast period. The presence of ample opportunities for the market development, coupled with the rapidly changing healthcare sector, is adding to the glucose tolerance test market growth in the region.
The global glucose tolerance test market in the MEA is predicted to have the smallest share over the forecast period for the slow & poor developing countries, particularly in the African region.
Browse Complete Toc :https://www.marketresearchfuture.com/reports/glucose-tolerance-test-market-4921
Leading players profiled in the global glucose tolerance test report include Medtronic PLC, Sanofi, LifeScan, Inc., F. Hoffman-La Roche Ltd, Abbott Laboratories, Dexcom, Inc., and Panasonic. Industry players have incorporated several strategies to create a niche in the market and also cater to the consumers growing needs. These strategies comprise partnerships, collaborations, joint ventures, mergers and acquisitions, new product development and launches, extensive R&D activities, contracts, geographic expansions, strategic alliances, and more.